Drug intelligence / Profile preview

Amogh Ashmari RFT Syrup

Development stage: Unknown
Lead developer: Amogh Pharmaceuticals
Administration: Oral

Overview

Amogh Ashmari RFT Syrup is an Ayurvedic polyherbal formulation developed by Amogh Pharmaceuticals, primarily indicated for kidney care, specifically for the management of renal calculi (kidney stones) and urinary tract infections. The term "Ashmari" in its name refers to stones in Ayurvedic terminology, while "RFT" likely stands for Renal Function Test support. It is marketed as a natural litholytic and diuretic agent that helps in the disintegration and expulsion of urinary stones and maintains overall renal health. The syrup is part of a consumer health product line that includes various herbal remedies for liver care, immunity, and diabetes.

Brand names: Amogh Ashmari RFT Syrup
Other names: Ashmari RFT Syrup

Beyond the preview

Go deeper on Amogh Ashmari RFT Syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amogh Ashmari RFT Syrup.

Explore the full profile